AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS
Go back to AC Immune Presents New Phase 1 Data Indicating Higher Uptake of TDP-43 PET Tracer ACI-19626 in Patients with ALS| (NASDAQ: ACIU) | Delayed: 2.40 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.40 | 52 Week High | $19.97 | |||
| Open | $2.40 | 52 Week Low | $10.36 | |||
| Day High | $2.40 | P/E | N/A | |||
| Day Low | $2.40 | EPS | $0.00 | |||
| Volume | 78 | |||||
